CME Q4 adjusted profit beats estimates on record volume

Reuters
02/04
CME Q4 adjusted profit beats estimates on record volume 

Overview

  • Derivatives marketplace's Q4 revenue missed analyst expectations

  • Adjusted net income for Q4 beat analyst estimates

  • Company reported fourth consecutive year of record annual revenue

Outlook

  • CME Group plans to expand access through U.S. Treasury clearing and 24/7 cryptocurrency trading

  • Company aims to increase average daily margin efficiencies for market users

  • CME Group to focus on prediction markets as part of future growth strategy

Result Drivers

  • RECORD VOLUME - Achieved highest Q4 volume on record with 27.4 mln contracts, driven by 12% growth in commodities and 5% in financials

  • INTERNATIONAL GROWTH - Non-U.S. average daily volume increased 9%, with Asia up 18% and EMEA up 6%

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Miss

$1.60 bln

$1.65 bln (10 Analysts)

Q4 EPS

$3.24

Q4 Adjusted Net Income

Beat

$1 bln

$982.40 mln (8 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy", 5 "hold" and 3 "sell" or "strong sell"

  • The average consensus recommendation for the financial & commodity market operators & service providers peer group is "buy."

  • Wall Street's median 12-month price target for CME Group Inc is $302.00, about 3% above its February 3 closing price of $293.07

  • The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 23 three months ago

Press Release: ID:nPn3VqG3fa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10